These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20102126)

  • 1. Clip & save: drug chart 2009 in review.
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):11-2. PubMed ID: 20102126
    [No Abstract]   [Full Text] [Related]  

  • 2. Clip & Save Drug Chart: FDA-approved drugs to treat sleep disorders.
    J Psychosoc Nurs Ment Health Serv; 2010 Oct; 48(10):7-8. PubMed ID: 20954585
    [No Abstract]   [Full Text] [Related]  

  • 3. "Off-label" psychotropic medication use in children.
    Regan J; Alderson A
    Tenn Med; 2003 Sep; 96(9):429-31. PubMed ID: 14513532
    [No Abstract]   [Full Text] [Related]  

  • 4. Twenty-three psychotropic drugs used in children abroad which are not recommended in the United States.
    Simeon J; Utech C; Simeon S
    Psychopharmacol Bull; 1975 Apr; 11(2):31-8. PubMed ID: 1135367
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology. The medication merry-go-round.
    Brown K
    Science; 2003 Mar; 299(5613):1646-9. PubMed ID: 12637713
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory issues in pediatric psychopharmacology.
    Laughren TP
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1276-82. PubMed ID: 8885581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence].
    Hebebrand J; Gerlach M
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786
    [No Abstract]   [Full Text] [Related]  

  • 9. [International WHO scientific programs concerning biological psychiatry and psychopharmacology (review of the literature)].
    Vartanian FE; Morozov PV; Prilipko LL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):146-50. PubMed ID: 2158716
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.
    Ereshefsky L; Jann MW; Saklad SR; Davis CM
    J Clin Psychiatry; 1986 Sep; 47 Suppl():6-15. PubMed ID: 3528134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of smoking cessation drugs by the Food and Drug Administration.
    Richins C
    Food Drug Law J; 2009; 64(2):277-90. PubMed ID: 19999284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHARMACopsychiatry: problematic but promising.
    Menkes DB
    N Z Med J; 2002 Feb; 115(1148):62-3. PubMed ID: 11913933
    [No Abstract]   [Full Text] [Related]  

  • 13. Disparities in drug development: the Japanese paradox.
    Kanba S
    J Psychiatry Neurosci; 1999 Jan; 24(1):13-4. PubMed ID: 9987203
    [No Abstract]   [Full Text] [Related]  

  • 14. Clip & save: drug chart. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260
    [No Abstract]   [Full Text] [Related]  

  • 15. New additions to the psychopharmacopia: extended release formulations.
    Roman MW
    Issues Ment Health Nurs; 2011; 32(11):717-9. PubMed ID: 21992264
    [No Abstract]   [Full Text] [Related]  

  • 16. [Patient education and specialty prescription information from the psychiatric viewpoint].
    Linden M
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):662-7; discussion 667-8. PubMed ID: 9527465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Off-label use of drugs in psychiatry and neurology].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multicenter psychopharmacologic research and the data bank].
    Cassano GB; Conti L; Massimetti G
    Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports.
    Alper K; Schwartz KA; Kolts RL; Khan A
    Biol Psychiatry; 2007 Aug; 62(4):345-54. PubMed ID: 17223086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strattera approved to treat ADHD.
    FDA Consum; 2003; 37(2):4. PubMed ID: 12715751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.